Get started
RocketTickers

Halozyme Announces Roche Receives FDA Approval For Phesgo(TM) (F

Long
Halozyme Therapeutics, Inc. (NASDAQ:HALO)  
RocketTickers  
NASDAQ:HALO   Halozyme Therapeutics, Inc.
Beyond Technical Analysis
4
0
beyondta
HALO: Halozyme Therapeutics, Inc.
2020-06-29 12:54:00
Halozyme Announces Roche Receives FDA Approval For Phesgo(TM) (Fixed-Dose Combination Of Perjeta® And Herceptin® For Subcutaneous Injection) Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With HER2-Positive Breast Cancer
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.